Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Clinical trial NCT02678312 · COMPLETED
Trial details
- NCT number
- NCT02678312
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2022-01-03
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.